S
Sucha O. Asbell
Researcher at Albert Einstein Medical Center
Publications - 95
Citations - 13717
Sucha O. Asbell is an academic researcher from Albert Einstein Medical Center. The author has contributed to research in topics: Radiation therapy & Prostate cancer. The author has an hindex of 44, co-authored 95 publications receiving 13110 citations. Previous affiliations of Sucha O. Asbell include Wayne State University & Yeshiva University.
Papers
More filters
Journal ArticleDOI
Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
Laurie E. Gaspar,Charles E. Scott,Marvin Rotman,Sucha O. Asbell,Theodore L. Phillips,Todd H. Wasserman,W. Gillies McKenna,Roger W. Byhardt +7 more
TL;DR: An analysis of tumor/patient characteristics and treatment variables in previous Radiation Therapy Oncology Group (RTOG) brain metastases studies was considered necessary to fully evaluate the benefit of these new interventions.
Journal ArticleDOI
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.
Jay S. Cooper,Matthew D. Guo,Arnold Herskovic,John S. Macdonald,James A. Martenson,Muhyi Al-Sarraf,Roger W. Byhardt,Anthony H. Russell,Jonathan J. Beitler,Sharon A. Spencer,Sucha O. Asbell,Mary V. Graham,Lawrence L. Leichman +12 more
TL;DR: Combined therapy increases the survival of patients who have squamous cell or adenocarcinoma of the esophagus, T1-3 N0-1 M0, compared with RT alone, and severe acute toxic effects also were greater in the combined therapy groups.
Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials
Walter J. Curran,Charles B. Scott,John Horton,James S. Nelson,Alan S. Weinstein,A. J. Fischbach,C. H. Chang,Marvin Rotman,Sucha O. Asbell,Robert E. Krisch,D. F. Nelson +10 more
TL;DR: This study of malignant glioma patients used a non-parametric statistical technique to examine the associations of both pretreatment patient and tumor characteristics and treatment-related variables with survival duration and permits examination of the interaction between prognostic variables not possible with other forms of multivariate analysis.
Journal ArticleDOI
Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials
Walter J. Curran,Charles B. Scott,John Horton,James S. Nelson,Alan S. Weinstein,A. Jennifer Fischbach,Chu H. Chang,Marvin Rotman,Sucha O. Asbell,Robert E. Krisch,D. F. Nelson +10 more
TL;DR: In this paper, the authors used a nonparametric statistical technique to examine the associations of both pretreatment patient and tumor characteristics and treatment-related variables with survival duration for malignant glioma patients.
Journal ArticleDOI
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.
Miljenko V. Pilepich,Kathryn Winter,Colleen A. Lawton,Robert E. Krisch,Harvey B. Wolkov,Benjamin Movsas,Eugen B. Hug,Sucha O. Asbell,David J. Grignon +8 more
TL;DR: In a population of patients with unfavorable prognosis carcinoma of the prostate, androgen suppression applied as an adjuvant after definitive RT was associated not only with a reduction in disease progression but in a statistically significant improvement in absolute survival.